Healthcare Providers’ Adherence to Recommended Pneumococcal and Influenza Vaccination in Patients Discharged with Respiratory Diseases from General Medical Wards
Abstract
:1. Introduction
Research Objectives
2. Materials and Methods
2.1. Study Design and Clinical Settings
2.2. Data Sources and Collection
2.3. Statistics
3. Results
4. Discussion
Study Limitations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
ACIP | Advisory Committee on Immunization Practices |
CDC | Center for Disease Control and Prevention |
ICU | Intensive Care Unit |
COVID-19 | Coronavirus Disease of 2019 |
KSMC | King Saud Medical City |
MOH | Ministry of Health |
HIV | Human Immunodeficiency Virus |
COPD | Chronic obstructive pulmonary disease |
PCV13 | Pneumococcal Conjugate Vaccine |
PPSV23 | Pneumococcal Polysaccharide Vaccine |
References
- Recommended Adult Immunization Schedule for Ages 19 Years or Older; CDC: Atlanta, GA, USA, 2022. Available online: www.cdc.gov/vaccines/schedules/hcp/imz/adult.html (accessed on 17 February 2022).
- Kroger, A.; Bahta, L.; Hunter, P. General Best Practice Guidelines for Immunization. Best Practices Guidance of the Advisory Committee on Immunization Practices (ACIP). Available online: www.cdc.gov/vaccines/hcp/acip-recs/general-recs/downloads/generalrecs.pdf (accessed on 13 December 2022).
- Ferdinands, J.M.; Gaglani, M.; Martin, E.T.; Middleton, D.; Monto, A.S.; Murthy, K.; Silveira, F.P.; Talbot, H.K.; Zimmerman, R.; Alyanak, E.; et al. Prevention of influenza hospitalization among adults in the United States, 2015–2016: Results from the US hospitalized adult influenza vaccine effectiveness network (HAIVEN). J. Infect. Dis. 2019, 220, 1265–1275. [Google Scholar] [CrossRef] [PubMed]
- Tenforde, M.W.; Talbot, H.K.; Trabue, C.H.; Gaglani, M.; McNeal, T.M.; Monto, A.S.; Martin, E.T.; Zimmerman, R.K.; Silveira, F.P.; Middleton, D.B.; et al. Influenza vaccine effectiveness against hospitalization in the United States, 2019–2020. J. Infect. Dis. 2021, 224, 813–820. [Google Scholar] [CrossRef] [PubMed]
- Johnstone, J.; Marrie, T.J.; Eurich, D.T.; Majumdar, S.R. Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch. Intern. Med. 2007, 167, 1938–1943. [Google Scholar] [CrossRef] [PubMed]
- Implementing the Immunization Agenda 2030; WHO: Geneva, Switzerland, 2021; Available online: https://www.who.int/publications/m/item/implementing-the-immunization-agenda-2030 (accessed on 14 December 2022).
- Annual Yearbook 2018. General Authority of Statistics in Saudi Arabia. Available online: https://www.stats.gov.sa/en/46 (accessed on 14 December 2022).
- Anokute, C.C. Assessment of compliance with the expanded program on immunization schedule in King Khalid University Hospital. J. Natl. Med. Assoc. 1989, 81, 293–295. [Google Scholar] [PubMed]
- Hutchins, S.S.; Sherrod, J.; Bernier, R. Assessing immunization coverage in private practice. J. Natl. Med. Assoc. 2000, 92, 163–168. [Google Scholar] [PubMed]
- Alqahtani, A.S.; Althobaity, H.M.; Al Aboud, D.; Abdel-Moneim, A.S. Knowledge and attitudes of Saudi populations regarding seasonal influenza vaccination. J. Infect. Public Health 2017, 10, 897–900. [Google Scholar] [CrossRef] [PubMed]
- Alluheibi, S.M.; Allehaiby, A.H.; Aseeri, T.A.; Alqahtani, A.S.; Althumali, J.A.; Abudaia, O.A. A review of knowledge, attitude and prevalence of flu vaccination and its effect among elderly. Egypt J. Hosp. Med. 2017, 69, 2680–2684. [Google Scholar] [CrossRef]
- Williams, W.W.; Lu, P.; O’Halloran, A.; Kim, D.K.; Grohskopf, L.A.; Pilishvili, T.; Skoff, T.H.; Nelson, N.P.; Harpaz, R.; Markowitz, L.E.; et al. Surveillance of Vaccination Coverage Among Adult Populations—United States, 2014. MMWR Surveill. Summ. 2016, 65, 1–36. [Google Scholar] [CrossRef] [PubMed]
- Estimates of Influenza Vaccination Coverage among Adults, 2017–18 Flu Season; CDC: Atlanta, GA, USA, 2018. Available online: https://www.cdc.gov/flu/fluvaxview/coverage-1718estimates.htm (accessed on 12 December 2022).
- Bloom, H.G.; Wheeler, D.A.; Linn, J. A managed care organization’s attempt to increase influenza and pneumococcal immunizations for older adults in an acute care setting. J. Am. Geriatr. Soc. 1999, 47, 106–110. [Google Scholar] [CrossRef] [PubMed]
- Pneumococcal Vaccination: Summary of Who and When to Vaccinate; CDC: Atlanta, GA, USA. Available online: https://www.cdc.gov/vaccines/vpd/pneumo/hcp/who-when-to-vaccinate.html (accessed on 14 December 2022).
- Grohskopf, L.A.; Blanton, L.H.; Ferdin, S.J.M.; Chung, J.R.; Broder, K.R.; Talbot, H.K.; Morgan, R.L.; Fry, A.M. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the ACIP—United States, 2022–23 Influenza Season. MMWR Recomm. Rep. 2022, 71, 1–28. [Google Scholar] [CrossRef] [PubMed]
- Orenstein, E.W.; ElSayed-Ali, O.K.; Aswamy, S.; Masterson, E.; Blanco, R.; Shah, P.; Lantis, P.; Kolwaite, A.; Dawson, T.E.; Ray, E.; et al. Evaluation of a Clinical Decision Support Strategy to Increase Seasonal Influenza Vaccination Among Hospitalized Children Before Inpatient Discharge. JAMA Netw. Open 2021, 4, e2117809. [Google Scholar] [CrossRef] [PubMed]
- Tartof, S.Y.; Qian, L.; Liu, I.A.; Tseng, H.F.; Sy, L.S.; Hechter, R.C.; Lewin, B.J.; Jacobsen, S.J. Safety of influenza vaccination administered during hospitalization. Mayo Clin. Proc. 2019, 94, 397–407. [Google Scholar] [CrossRef] [PubMed]
- Vaccine Schedules in All Countries in the EU/EEA; ECDC: Stockholm, Sweden, 2013; Available online: https://vaccine-schedule.ecdc.europa.eu/ (accessed on 12 December 2022).
- Anderson, E.L. Recommended solutions to the barriers to immunization in children and adults. Mol. Med. 2014, 111, 344–348. [Google Scholar]
Total Number of Patients (N = 190). | |
---|---|
Age, years | |
Mean ± SD | 55.5 ± 21.32 |
Median (IQR) | 56.05 (38) |
Male sex,n(%) | 104 (54.7) |
Preexisting comorbidities | |
Ischemic heart diseases, n (%) | 27 (14.2) |
Hypertension, n (%) | 79 (41.5) |
Diabetes mellitus, n (%) | 113 (59.4) |
Underlying lung diseases, n (%) | 135 (71) |
Diagnosis on admission | |
Pneumonia, n (%) | 121 (63.7) |
Asthma and COPD exacerbation, n (%) | 52 (27.4) |
Other respiratory infections, n (%) | 17 (8.9) |
Number of admissions per index period, Mean ± SD | 1 ± 0.93 |
Patient admitted twice or more during the indexed period, n(%) | 48 (25.3) |
Length of hospital stay, days | |
Mean ± SD | 12 ± 23.1 |
Median (IQR) | 7 (7) |
Antibiotics prescribing at discharge, n(%) | 102 (53.7) |
Immunizations recommended at discharge, n(%) | 0 (0) |
Documented immunization history prior to hospital admission or within 6 months of discharge, n(%) | 0 (0) |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Alshehri, A.; Ahmed, M.; Bagazi, D.; Alghamdi, A. Healthcare Providers’ Adherence to Recommended Pneumococcal and Influenza Vaccination in Patients Discharged with Respiratory Diseases from General Medical Wards. Vaccines 2023, 11, 431. https://doi.org/10.3390/vaccines11020431
Alshehri A, Ahmed M, Bagazi D, Alghamdi A. Healthcare Providers’ Adherence to Recommended Pneumococcal and Influenza Vaccination in Patients Discharged with Respiratory Diseases from General Medical Wards. Vaccines. 2023; 11(2):431. https://doi.org/10.3390/vaccines11020431
Chicago/Turabian StyleAlshehri, Amani, Marwa Ahmed, Doaa Bagazi, and Ahmad Alghamdi. 2023. "Healthcare Providers’ Adherence to Recommended Pneumococcal and Influenza Vaccination in Patients Discharged with Respiratory Diseases from General Medical Wards" Vaccines 11, no. 2: 431. https://doi.org/10.3390/vaccines11020431